IP Library Granted Patent US 10,525,164
Granted Patent B2
US 10,525,164 · App. 12/862,033 · Granted Jan 7, 2020

Vascular grafts derived from acellular tissue matrices

Inventors: Hui Xu (Plainsboro, NJ); Cunqi Cui (Plainsboro, NJ); Joshua Czeczuga (Brick, NJ); Jared Lombardi (Somerset, NJ)
Assignee: LifeCell Corporation
A61L27/3604A61F2/06A61L27/507A61L2430/36Y10T156/1002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,525,164
App. No.
12/862,033
Granted
Jan 7, 2020
Kind
B2
Abstract

A vascular graft for treatment of diseased or damaged blood vessels is disclosed. The graft comprises a sheet of acellular tissue matrix with an intact basement membrane. The graft is formed by wrapping the sheet into a tube and securing the edges of the sheet together. The acellular tissue matrix facilitates tissue ingrowth and remodeling of the graft with host cells.

Claims (11)

1. A vascular graft, comprising:

an anticoagulant;

a tubular conduit having a lumen for the passage of blood therethrough wherein the tubular conduit consists essentially of a single sheet of dermal acellular tissue matrix having a basement membrane, the basement membrane disposed along an inner surface of the lumen and the single sheet forming a single layer wall around the lumen; and

an adhesive comprising fibrinogen attaching a first longitudinal edge of the acellular tissue matrix to a second longitudinal edge of the acellular tissue matrix to form a fluid-tight seam extending along a length of the vascular graft.

2. The vascular graft of claim 1 , wherein attaching the first and the second longitudinal edges with the adhesive creates a longitudinal ridge protruding from an abluminal surface of the tubular wall.

3. The vascular graft of claim 1 , wherein the first and the second longitudinal edges are attached using a combination of sutures and the adhesive.

4. The vascular graft of claim 1 , wherein the dermal matrix is derived from human skin.

5. The vascular graft of claim 1 , wherein the acellular tissue matrix is derived from tissue that is xenogeneic to a human recipient.

6. The vascular graft of claim 5 , wherein the tissue is from an 1,3-galactosyltransferase (α1,3GT) deficient pig.

7. The vascular graft of claim 1 , wherein the acellular tissue matrix is derived from tissue that is allogeneic to a human recipient.

8. The vascular graft of claim 1 , wherein the anticoagulant comprises heparin.

Assignments (8)
RELEASE OF SECURITY INTEREST 040098/0268 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0554 →
RELEASE OF SECURITY INTEREST 040291/0237 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0702 →
RELEASE OF SECURITY INTEREST 037845/0497 Recorded Feb 2, 2017
From: WILMINGTON TRUST
To: LIFECELL CORPORATION
Reel/Frame 041608/0603 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY INTEREST Recorded Feb 17, 2016
From: KINETIC CONCEPTS, INC.; KCI USA, INC.; ACELITY L.P. INC.; CHIRON HOLDINGS, INC.; CHIRON TOPCO, INC.; KCI ANIMAL HEALTH, LLC; KCI HOLDING COMPANY, INC.; KCI HOMECARE, INC.; KCI IMPORTS, INC.; KCI INTERNATIONAL, INC.; KCI LICENSING, INC.; KCI PROPERTIES LIMITED; KCI REAL HOLDINGS, L.L.C.; KCI REAL PROPERTY LIMITED; KCI USA REAL HOLDINGS, L.L.C.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 037845/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2015
From: XU, HUI; CUI, CUNQI; CZECZUGA, JOSHUA; LOMBARDI, JARED
To: LIFECELL CORPORATION
Reel/Frame 036765/0161 →
TERMINATION OF SECURITY INTEREST IN PATENTS Recorded Jan 7, 2011
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: KINETIC CONCEPTS, INC.; KCI LICENSING, INC.; LIFECELL CORPORATION
Reel/Frame 025599/0904 →